Eastgate Biotech Corp.
ETBI · OTC
9/30/2017 | 6/30/2017 | 3/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $14 | $10 |
| - Cash | $0 | $0 | $0 | -$0 |
| + Debt | $3 | $2 | $2 | $2 |
| Enterprise Value | $4 | $3 | $15 | $12 |
| Revenue | $0 | $0 | $0 | -$0 |
| % Growth | -79.8% | – | 100% | – |
| Gross Profit | -$0 | $0 | $0 | -$0 |
| % Margin | -299.1% | 50.3% | – | 85.1% |
| EBITDA | -$2 | $0 | -$1 | -$1 |
| % Margin | -7,439.6% | 0% | – | 953.2% |
| Net Income | -$2 | -$1 | -$1 | -$1 |
| % Margin | -7,057.2% | -624.3% | – | 999.2% |
| EPS Diluted | -0.002 | -0.001 | -0.003 | -0.003 |
| % Growth | -25% | 60% | 3.2% | – |
| Operating Cash Flow | -$1 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | -$0 | -$0 | -$0 |